LEP and breast carcinoma: Postmenopausal women with an increased risk of breast cancer show improved hormonal (bioavailable estradiol, testosterone, and insulin) and adipocytokine (relative adiponectin/leptin, C-reactive protein) markers of breast cancer in serum and breast tissue with weight loss of more than 10% [225].